PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Releases Twelve New Catalog Peptides - Continuing to secure its position as one of the top two providers of catalog peptides in the world, this week AnaSpec introduced a selection of new peptides for drug discovery research
AnaSpec Releases Twelve New Catalog Peptides

 

NewswireToday - /newswire/ - San Jose, CA, United States, 2007/01/18 - Continuing to secure its position as one of the top two providers of catalog peptides in the world, this week AnaSpec introduced a selection of new peptides for drug discovery research.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bacterial Peptides
CFTR (108-117); Pseudomonas aeruginosa Inhibitor (Cat# 61810-1/61810-5)
Sequence: SYDPDNKEER
This peptide represents amino acids 108-117 of the first CFTR(human cystic fibrosis transmembrane conductance regulator) extracellular domain. This peptide has been shown to inhibit internalization of Pseudomonas aeruginosa.

Protein Phosphorylation Related Peptides
Histone H3 (116–136); C116–136 (Cat# 61704)
Sequence: KRVTIMPKDIQLARRIRGERA
This peptide spans the C-terminus of histone H3; amino acids 116 to 136.

Histone H3 (1-21); Biotinylated (Cat# 61702)
Sequence: ARTKQTARKSTGGKAPRKQLA-GG-K(BIOTIN)-NH2
This sequence corresponds to the first 21 amino acids of the NH2 terminal of histone H3 followed by a GG linker and a biotinylated lysine. This peptide was used to investigate the characteristics and mechanisms of ethanol-induced histone H3 acetylation in rat hepatocytes. Immunocytochemical and immunoblot analyses revealed that ethanol treatment significantly increased H3 acetylation at Lys9 with negligible effects at Lys14; 18; and 23.

RS domain derived peptide (Cat# 61722)
Sequence: GRSRSRSRSR
This peptide is a substrate for Clk/Sty and is phosphorylated by Clk/Sty protein kinase (Km=102 microM).

BTK derived peptide (Cat# 61728)
Sequence: KKVVALYDYMPMN-NH2
BTK derived peptide is a substrate for Btk (Bruton's tyrosine kinase); a nonreceptor tyrosine kinase; involved in precursor B (pre-B) cell receptor signal which is required for normal B cell development and signal transduction through cell surface molecule.

Histone H3 (116–136); N15–39 (Cat# 61705)
Sequence: APRKQLATKAARKSAPATGGVKKPH
This peptide is based on amino acids 15 to 39 of histone H3.

Forkhead derived peptide; FAM-labeled; Woodtide (Cat# 61744)
Sequence: 5-FAM-KKISGRLSPIMTEQ-NH2
A FAM-labeled Forkhead derived peptide (Ab/Em = 494/521 nm). Also known as woodtide; this peptide is used as a substrate for the DYRK family of kinases in in-vitro analysis. The peptide corresponds to residues 324-334 of transcription factor FKHR with two lysine residues added at the N-terminus to facilitate binding to phosphocellulose paper.

Forkhead derived peptide; Woodtide (Cat# 61743)
Sequence: KKISGRLSPIMTEQ-NH2
This peptide is used as a substrate for the DYRK family of kinases in in-vitro analysis. Also known as woodtide; this peptide corresponds to residues 324 to 334 of transcription factor FKHR with two lysine residues added at the N-terminus to facilitate binding to phosphocellulose paper.

Viral Peptides
LMP2 (340–350); SSC (Cat# 61681)
Sequence: SSCSSCPLSKI
This is an Epstein-Barr virus (EBV)-encoded oncogene latent membrane protein 2 (LMP2); HLA-A11 restricted subdominant epitope. The SSC-specific effector CTLs; active against both the peptide and endogenously expressed LMP2 protein; could be generated from donor (HLA-A11-positive) by stimulation with SSC-loaded dendritic cells(SSC/DC).

LMP2 (419-427); TYG (Cat# 61683)
Sequence: TYGPVFMCL
This is a HLA A*2402-restricted Epstein-Barr virus (EBV)-encoded oncogene latent membrane protein 2 (LMP2) epitope fragment amino acid residues 419 to 427.

HIV QK10 (Cat# 61672)
Sequence: QVPLRMTYK
This is a HLA A3 restricted HIV Nef epitope (QK10); a conserved CTL epitope within a functional domain of nef. It overlaps with CTL epitopes restricted by HLA A11; B7 and B35.

Neuropeptides
L1ARSLCD (Cat# 61661)
Sequence: FGEARSLESDNEE
This peptide has a single amino acid substitution (Y1176A) at critical tyrosine residue compared to L1CD (1173-1185). It corresponds to the mutant form of L1 amino acids 1173 to 1185. The L1 subfamily of cell adhesion molecules (CAMs) has a highly conserved cytoplasmic domain that contains a tyrosine; followed by the alternatively spliced RSLE (Arg-Ser-Leu-Glu) sequence.

For more information visit our website.

Company Info

AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.
AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development.

Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA. AnaSpec maintains ISO9001 certification, holds a California Drug Manufacturing License and a FDA Registration for GMP Drug Manufacturing.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Releases Twelve New Catalog Peptides

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Debra Thai 
408-452-5055 marketing[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)